| Literature DB >> 35413925 |
Hongwen Liu1,2, Li Yin3, Jiao Li3, Shaojiang Liu1, Qifeng Tao1, Jie Xu4.
Abstract
BACKGROUND: Minimally anterolateral approach (MAA) and direct anterior approach (DAA) have been reported as beneficial for total hip arthroplasty (THA) due to their ability to reduce postoperative pain and lead to quicker rehabilitation by preserving muscle insertions. As there is an ongoing debate on the effect of these two approaches on early postoperative outcomes, this prospective study aimed to assess the difference in early clinical, radiological, and patient-reported outcomes between the two minimally invasive approaches.Entities:
Keywords: Direct anterior approach; Early results; Minimally anterolateral approach; Total hip arthroplasty
Mesh:
Substances:
Year: 2022 PMID: 35413925 PMCID: PMC9003954 DOI: 10.1186/s13018-022-03126-0
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Patient selection chart
Demographic data on the patients
| Variable | MAA | DAA | |
|---|---|---|---|
| Age (years) | 62.44 ± 7.07 | 62.21 ± 8.22 | 0.881 |
| Males/females ( | 17 (34.0%)/33(66.0%) | 23 (47.9%)/25(52.1%) | 0.161 |
| BMI (kg/m2) | 22.46 ± 4.23 | 22.96 ± 3.11 | 0.509 |
| Operative side—right ( | 23 (46.0%) | 25 (52.1%) | 0.547 |
| ASA score (I:II:III) | 11/30/9 | 9/34/5 | 0.460 |
| 6 MWT (m) | 289 ± 51.36 | 279.17 ± 57.05 | 0.372 |
| Pre-op VAS (points) | 7.32 ± 1.02 | 7.23 ± 1.12 | 0.675 |
| Pre-op JOA (points) | |||
| Pain | 16.74 ± 4.58 | 16.73 ± 5.37 | 0.991 |
| ROM | 12.98 ± 2.99 | 12.21 ± 3.29 | 0.227 |
| Gait | 10.54 ± 3.45 | 11.02 ± 3.49 | 0.494 |
| ADL | 11.32 ± 3.63 | 10.35 ± 3.08 | 0.160 |
| Total | 51.58 ± 9.69 | 50.31 ± 9.77 | 0.521 |
Surgical and immediate postoperative data
| Variable | MAA | DAA | |
|---|---|---|---|
| Surgery time (min) | 62.4 ± 9.05 | 71 ± 8.01 | |
| Incision (cm) | 9.86 ± 0.99 | 10.04 ± 1.07 | 0.385 |
| Blood loss (ml) | 132.6 ± 43.31 | 159.23 ± 37.25 | |
| Hb drop (g/L) | 29.56 ± 8.02 | 36.4 ± 7.12 | |
| Blood transfusion ( | 2 (4.0%) | 9 (18.8%) | |
| Post-op hospital stay (day) | 4.6 ± 1.14 | 4.77 ± 1.17 | 0.467 |
| VAS (points) | |||
| 1 day post‐op | 4.2 ± 0.99 | 4.38 ± 0.82 | 0.343 |
| 3 day post‐op | 2.82 ± 0.83 | 2.79 ± 0.8 | 0.863 |
| 7 day post‐op | 2.24 ± 0.52 | 2.38 ± 0.57 | 0.222 |
| Cup inclination (°) | 41.96 ± 4.45 | 40.71 ± 4.09 | 0.151 |
| Cup anteversion (°) | 16.64 ± 5.63 | 15.92 ± 5.01 | 0.504 |
| Femoral stem position ( | 0.963 | ||
| Valgus | 0 (0%) | 0 (0%) | |
| Neutral | 48 (96.0%) | 45 (93.8%) | |
| Varus | 2 (4.0%) | 3 (6.2%) |
P value < 0.05 was shown in bold
Fig. 2Surgical and immediate postoperative difference data: surgery time, blood loss, Hb drop, and the number of blood transfusions
Postoperative outcomes data
| Variable | 2 weeks | 6 weeks | 12 weeks | ||||||
|---|---|---|---|---|---|---|---|---|---|
| MAA | DAA | MAA | DAA | MAA | DAA | ||||
| VAS (points) | 2.16 ± 1.2 | 2.29 ± 1.32 | 0.607 | 1.86 ± 1.16 | 1.85 ± 1.24 | 0.981 | 1.4 ± 1.14 | 1.13 ± 0.84 | 0.180 |
| Stairs normally ( | 16 (32.0%) | 14 (29.2%) | 0.761 | 24 (48.0%) | 26 (54.2%) | 0.542 | 42 (84.0%) | 36 (75.0%) | 0.269 |
| Distance unlimited ( | 25 (50.0%) | 20 (41.7%) | 0.408 | 38 (76.0%) | 39 (81.3%) | 0.527 | 42 (84.0%) | 42 (87.5%) | 0.621 |
| Shoes and socks with Ease ( | 21 (42.0%) | 24 (50.0%) | 0.427 | 36 (72.0%) | 32 (66.7%) | 0.567 | 42 (84.0%) | 43 (89.6%) | 0.415 |
| 6MWT(m) | 225 ± 87.74 | 238.54 ± 86.17 | 0.443 | 346.6 ± 86.26 | 332.29 ± 72.24 | 0.377 | 410.6 ± 82.69 | 425.83 ± 86.44 | 0.375 |
| FJS-12 (points) | 64.5 ± 17.96 | 55.52 ± 13.18 | 74.9 ± 13.98 | 68.65 ± 13.84 | 80.2 ± 13.21 | 78.54 ± 16.44 | 0.582 | ||
| JOA (points) | |||||||||
| Pain | 29.2 ± 4.5 | 30.81 ± 5.17 | 0.102 | 36.76 ± 2.54 | 36.02 ± 2.42 | 0.143 | 38.98 ± 1.8 | 38.44 ± 2.61 | 0.232 |
| ROM | 13.88 ± 3.27 | 14.5 ± 3.59 | 0.373 | 16.28 ± 1.33 | 16.52 ± 2.41 | 0.539 | 16.96 ± 1.73 | 17.38 ± 1.95 | 0.267 |
| Gait | 13.6 ± 2.96 | 12.94 ± 3.48 | 0.312 | 14.1 ± 3.87 | 15.33 ± 3.22 | 0.090 | 18.06 ± 1.75 | 17.42 ± 2.56 | 0.148 |
| ADL | 13.9 ± 3.02 | 14.44 ± 2.7 | 0.356 | 15.04 ± 3.52 | 15.88 ± 3.55 | 0.245 | 16.76 ± 1.51 | 17.25 ± 1.64 | 0.127 |
| Total | 70.58 ± 7.49 | 72.69 ± 9.09 | 0.213 | 82.52 ± 7.62 | 84.33 ± 6.77 | 0.217 | 90.76 ± 3.16 | 90.48 ± 6.97 | 0.797 |
P value < 0.05 was shown in bold
Fig. 3Postoperative outcomes and surgical complications difference data: FJS-12 and the number of LCFN neuropraxia
Surgical complications
| Complication | MAA ( | DAA ( | |
|---|---|---|---|
| Superficial infection (hips) | 0 | 0 | 1.00 |
| Deep infection | 0 | 0 | 1.00 |
| DVT | 0 | 0 | 1.00 |
| Calcar fracture | 0 | 0 | 1.00 |
| Major trochanteric fracture | 1 (2%) | 1 (2.1%) | 1.00 |
| LCFN neuropraxia | 0 | 7(14.6%) | |
| Nerve palsy | 0 | 0 | 1.00 |
| Postoperative dislocation | 0 | 0 | 1.00 |
| Postoperative femoral fracture | 0 | 0 | 1.00 |
| Cup migration | 0 | 0 | 1.00 |
| Stem subsidence > 3 mm (EBRA/FCA) | 0 | 0 | 1.00 |
| Thigh pain | 0 | 0 | 1.00 |
| Bursitis | 0 | 0 | 1.00 |
P value < 0.05 was shown in bold